Drug Information

Drug General Information
Drug ID
D03JZC
Former ID
DIB016132
Drug Name
PF-06263507
Drug Type
Antibody
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524349]
Company
Pfizer
Target and Pathway
Target(s) 5T4 ONCOFETAL antigen Target Info [550498]
References
Ref 524349ClinicalTrials.gov (NCT01891669) A Study Of PF-06263507 In Patients With Advanced Solid Tumors. U.S. National Institutes of Health.
Ref 550498National Cancer Institute Drug Dictionary (drug id 751006).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.